Indravaruni (Indravaruni (Aindri, Indrani, Chitra, Shvetapushpa)) - Ayurvedic Properties & Benefits

Indravaruni, scientifically known as Citrullus colocynthis, is a medicinal plant traditionally used for various ailments, including diabetes and gastrointe...

Indravaruni (Indravaruni (Aindri, Indrani, Chitra, Shvetapushpa))

Indravaruni, scientifically known as Citrullus colocynthis, is a medicinal plant traditionally used for various ailments, including diabetes and gastrointestinal disorders. Modern research focuses on its potential in managing type 2 diabetes and its antioxidant and anti-inflammatory properties. However, it should be used under strict medical supervision due to its toxicity.

Botanical name: Citrullus colocynthis. Also known as: Colocynth, Bitter Apple, Desert Gourd, Vine of Sodom, Bitter Cucumber, Indravaruni, Mahaphala, Dhamargava, Indrayan, Kala-Indrayan, Indrayan (Gujarati, Marathi), Kummatti (Tamil), Kumbuda (Telugu), Labbakayi (Kannada), Makhal (Bengali), Ghurunba (Punjabi), Handhal (Arabic), Paedikari Attutummatti (Tamil), Kadu Indravani (Marathi), Paikummatti (Malayalam), Maraghonae (Pashto).

Properties

Antidiabetic, Antimicrobial, Antioxidant, Anti-inflammatory

Dosage

General Dosage: It is crucial to consult with a qualified Ayurvedic practitioner before using Indravaruni. High doses can cause severe adverse effects. Dry Powder (Churna): 125–250 mg with honey or ghee, once daily after a light meal for mild constipation. However, some sources suggest a slightly higher dosage of fruit powder, 125-500 mg. Decoction (Kasaya): 3–6 g of raw fruit rind boiled in 200 ml of water, strained, and taken as 50 ml twice daily under supervision. Tincture/Liquid Extract: 2–5 ml of a 1:5 hydroalcoholic extract, diluted in water, once or twice daily. Root powder: 1-3 g

Classical attributes

Benefits

Traditional uses

Dosha effects

Preparation methods

Contraindications

Side effects

Interactions

Clinical evidence

Meta-analyses and databases tracking RCTs indicate Citrullus colocynthis can lead to a significant decrease in glycosylated hemoglobin (HbA1c) and fasting blood glucose (FBS) levels in type 2 diabetes patients. Further research is needed to evaluate the long-term efficacy and toxicity.

Ayurvedic karmas

Classical clinical indications